D-0854-2020 Class II Terminated

Recalled by American Health Packaging — Columbus, OH

FDA drug recall D-0854-2020 was initiated by American Health Packaging on Dec 4, 2019 and is designated Class II. Reason for recall: Failed Dissolution Specifications: Low out of specification results obtained during stability testing. The recall status is terminated (terminated Aug 4, 2022). Affected quantity: 973 cartons.

Recall details

Product Type
Drugs
Report Date
Feb 19, 2020
Initiation Date
Dec 4, 2019
Termination Date
Aug 4, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
973 cartons

Product description

Raloxifene Hydrochloride Tablets, USP, 60 mg, 30 Tablets (3 x 10 blister cards), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC carton: 60687-266-21; NDC Unit Dose: 60687-266-11

Reason for recall

Failed Dissolution Specifications: Low out of specification results obtained during stability testing.

Distribution pattern

Nationwide within the United States

Code information

Lot #:180276A, Exp date 02/29/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0854-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0854-2020. Report a data issue: hello@regdatalab.com.